Search research articles
Contact Us
Filters
Showing results (91-100 of 153) with videos related to
Page
of 16
Sort By:
International Journal of Cancer
|
May 14, 2026
Early-Life Exposures and Risk of Multiple Myeloma: A Population-Based Case-Control Study in Australia
Zhuoyu Sun, Julie K Bassett, Simon Cheah, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
December 15, 2023
Evaluating the cost-effectiveness of [<sup>18</sup>F]FDG-PET/CT for investigation of persistent or recurrent neutropenic fever in high-risk haematology patients
Michelle Tew, Abby P Douglas, Jeff Szer, et al.
European Journal of Haematology
|
June 15, 2021
Receiving four or fewer cycles of therapy predicts poor survival in newly diagnosed transplant-ineligible patients with myeloma who are treated with bortezomib-based induction
Stephen Boyle, Cameron Wellard, Elizabeth M Moore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 11, 2020
A Randomized Trial of Two 2-Dose Influenza Vaccination Strategies for Patients Following Autologous Hematopoietic Stem Cell Transplantation
Benjamin W Teh, Vivian K Y Leung, Francesca L Mordant, et al.
Bone Marrow Transplantation
|
May 20, 2021
Real-world utilisation of ASCT in multiple myeloma (MM): a report from the Australian and New Zealand myeloma and related diseases registry (MRDR)
Krystal Bergin, Cameron Wellard, Bradley Augustson, et al.
Internal Medicine Journal
|
April 24, 2023
Executive summary of consensus clinical practice guidelines for the prevention of infection in patients with multiple myeloma
Benjamin W Teh, Gemma Reynolds, Monica A Slavin, et al.
The British Journal of Nutrition
|
May 13, 2026
Diet and risk of multiple myeloma: findings from a case-control study
Simon Cheah, Allison M Hodge, Julie K Bassett, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 5, 2025
Real-World Comparison of Treatment Outcomes for Multiple Myeloma in Elderly Transplant Ineligible Patients Receiving First-Line VRd, Rd and VCd: Results From the Australian and New Zealand Myeloma and Related Diseases Registry
Sarah Zhao, Cameron Wellard, Elizabeth M Moore, et al.
Current Medical Research and Opinion
|
August 12, 2024
Comparative efficacy of ciltacabtagene autoleucel versus idecabtagene vicleucel in the treatment of patients with relapsed or refractory multiple myeloma previously treated with 2-4 prior lines of therapy: a matching-adjusted indirect comparison
Noffar Bar, Joris Diels, Suzy van Sanden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2012
Panobinostat in patients with relapsed/refractory Hodgkin's lymphoma after autologous stem-cell transplantation: results of a phase II study
Anas Younes, Anna Sureda, Dina Ben-Yehuda, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 153) with videos related to
Sort By:
Page
of 16
International Journal of Cancer
|
May 14, 2026
Early-Life Exposures and Risk of Multiple Myeloma: A Population-Based Case-Control Study in Australia
Zhuoyu Sun, Julie K Bassett, Simon Cheah, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
December 15, 2023
Evaluating the cost-effectiveness of [<sup>18</sup>F]FDG-PET/CT for investigation of persistent or recurrent neutropenic fever in high-risk haematology patients
Michelle Tew, Abby P Douglas, Jeff Szer, et al.
European Journal of Haematology
|
June 15, 2021
Receiving four or fewer cycles of therapy predicts poor survival in newly diagnosed transplant-ineligible patients with myeloma who are treated with bortezomib-based induction
Stephen Boyle, Cameron Wellard, Elizabeth M Moore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 11, 2020
A Randomized Trial of Two 2-Dose Influenza Vaccination Strategies for Patients Following Autologous Hematopoietic Stem Cell Transplantation
Benjamin W Teh, Vivian K Y Leung, Francesca L Mordant, et al.
Bone Marrow Transplantation
|
May 20, 2021
Real-world utilisation of ASCT in multiple myeloma (MM): a report from the Australian and New Zealand myeloma and related diseases registry (MRDR)
Krystal Bergin, Cameron Wellard, Bradley Augustson, et al.
Internal Medicine Journal
|
April 24, 2023
Executive summary of consensus clinical practice guidelines for the prevention of infection in patients with multiple myeloma
Benjamin W Teh, Gemma Reynolds, Monica A Slavin, et al.
The British Journal of Nutrition
|
May 13, 2026
Diet and risk of multiple myeloma: findings from a case-control study
Simon Cheah, Allison M Hodge, Julie K Bassett, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 5, 2025
Real-World Comparison of Treatment Outcomes for Multiple Myeloma in Elderly Transplant Ineligible Patients Receiving First-Line VRd, Rd and VCd: Results From the Australian and New Zealand Myeloma and Related Diseases Registry
Sarah Zhao, Cameron Wellard, Elizabeth M Moore, et al.
Current Medical Research and Opinion
|
August 12, 2024
Comparative efficacy of ciltacabtagene autoleucel versus idecabtagene vicleucel in the treatment of patients with relapsed or refractory multiple myeloma previously treated with 2-4 prior lines of therapy: a matching-adjusted indirect comparison
Noffar Bar, Joris Diels, Suzy van Sanden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2012
Panobinostat in patients with relapsed/refractory Hodgkin's lymphoma after autologous stem-cell transplantation: results of a phase II study
Anas Younes, Anna Sureda, Dina Ben-Yehuda, et al.
Page
of 16